The first two authors contributed equally to this study Mesenchymal stem cells (MSC) playa crucial role in endothelial repair after artery injury. The high mobility group box 1 (HMGBl) is a key modulator of the homing of MSC to impaired artery and endothelialization. This study was aimed to determine whether balloon-induced carotid artery injury could be improved by transplantation with MSC modified by HMGBI. MSC were infected by adenoviral serotype 5 encoding recombinant green fluorescent protein (GFP) gene and HMGBI (ad5GFP-HMGBl). The expression ofHMGBl, vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) was detected in MSC using Real-time PCR, Western blot and semi-quantitative immunohistochemical assays. In vivo, reendothelialization was examined in rats subjected to carotid artery injury. The homing of MSC was observed under fluorescence microscopy, and the levels of serum tumor necrosis factor-a (TNF-a) and C-reactive protein (CRP) was assessed by ELISA assay. As a result, compared with the MSC group, the expression of HMGBl, VEGF and PCNA was markedly increased, vascular reendothelialization was accelerated, and the levels of serum TNF-a and CRP were decreased in group ad5GFP and ad5GFP-HMGBl. Transplantation of MSC infected with adGFP-HMGBl strengthened the MSC effect. Taken together, modification ofHMGBl can enhance the protective effects ofMSC on balloon-induced carotid artery injury through up-regulation ofVEGF and PCNA expression and inhibition ofthe inflammatory response. HMGBI in MSC may represent a novel therapeutic target for the treatment of endothelial repair.
properties, and have prompted ongoing clinical trials to evaluate the safety and efficacy of MSC (8) .
MSC may exert their therapeutic benefits by promoting vascular repair and regeneration by modulating the pathological immune responses. Combined with genetic engineering with cell therapy, MSC may enhance the regenerative function of these cells (9) . MSC modified by heme oxygenase-l exhibit markedly enhanced anti-apoptotic and antioxidative capabilities, thus contributing to improved repair of ischemic myocardial injury through cell survival and VEGF production (10) . Prostaglandin I (2)-IP system is essential for endothelial progenitor cells (EPe) to accomplish their function and plays a critical role in the regulation of vascular remodeling (11) . Preconditioning MSC with transforming growth factor-alpha or TNF-alpha receptors improves MSC-mediated cardiac protection against ischemia (12, 13) . Modification with Suvivin could enhance the therapeutic effects of MSC possibly through improving the MSC survival capacity and up-regulating the expression of protective cytokines in the ischemic tissue (14) .
Interestingly, it is known to us that damageassociated molecular patterns (DAMP) enhance angiogenesis and prime the immune response. Among the DAMP, high mobility group box I (HMGB I) can act as a chemoattractant and activator of granulocytes. It is a key regulator of MSC processes, and stimulates the local proliferation of MSC (15) . Conversely, HMGB 1 is also considered to inhibit the proliferation of human MSC and promote their migration and differentiation along osteoblastic pathway (16) . Accordingly, HMGBI may be an available molecular target of gene therapy for MSC.
To date, few reports have shown the effects of HMGB I gene transfer on functional properties and in vivo reendothelialization capacity of MSC. Given the association between HMGB 1 signaling and MSC, we hypothesized that HMGB I gene transfer might promote MSC-mediated endothelial repair after artery injury. To address this assumption, we evaluated the effects of HMGB 1 gene on the expression of VEGF and PCNA as well as in vivo vascular reendothelialization after balloon-induced carotid artery injury in rats. We also investigated the homing of MSC and the levels of serum TNF-a and CRP related to inflammation by ELISA assay.
MATERIALS AND METHODS

Materials
Male Sprague-Dawley rats were purchased from Shanghai Laboratory Animal Center of Chinese Academy Sciences. Adenovirus-mediated HMGB 1 vector and a negative control vector were purchased from Genechem (Shanghai, China). Plasmids were extracted and purified using plasmid maxi kit (Qiagen, Valencia,CA). The primers of HMGBl, PCNA and VEGF were synthesized by ABI (USA). All antibodies were from Santa Cruz Biotechnology (USA). ELISA kit was from BD Biosciences.
Preparation ofMSC
MSC were prepared from rat bone marrow. In brief, we euthanized Sprague Dawley (SD) rats weighted 80-100 g and harvested bone marrow. Bone marrow cells were introduced into 100-mm dishes and cultured in complete medium, consisting of Dulbecco's Modified Eagle's Medium (DMEM; Sigma) containing 10% fetal bovine serum and antibiotics. Culture medium was replaced every three days and floating cells were discarded. Following two passes, the attached cells were divided into three new flasks and cultured until the cell density of the colonies grew to approximately 90% confluence. These cells were analyzed by fluorescence-activated cell sorting.
Flow cytometry analysis
MSC marker proteins were examined by Flow cytometry analysis using monoclonal mouse anti-human antibodies recognizing CD29 and CD45 (BD, San Diego, CA, USA). Furthermore, expression of these proteins was analyzed. To determine the expression of each of these surface antigens, cells were incubated for 40 min at 48°C in a volume of 0.1 ml with an appropriate amount of antibody or corresponding IgG control.
HMGBI recombinant adenovirus vector construction
The full length HMGB I cDNA without termination colon was amplified by polymerase chain reaction (PCR) and inserted into the Age I site of the plasmid to form a GFP/HMGB 1 fusion gene. The identity of HMGB 1 cDNA obtained in this manner was confirmed by sequencing and comparing it with the Gene Bank sequence, NM_002128. The target sequence in mRNA (5'-3') is CCTTGTAACTGAAGATGATTT. The HMGB I recombinant adenovirus vector was prepared using Lipofectmaine 2000 transfection technology.
MSC gene modification
The MSC infected with HMGBI recombinant adenovirus were defined as HMGBI-GFP-MSC and the MSC infected with mock adenovirus were defined as GFP-MSC. To achieve the optimal gene transfer, polybrene was used. All MSC were expanded and then used for transplantation. The efficiency of gene transduction was assessed under fluorescence microscopy.
Quantitative Real-time peR
To quantitatively determine the mRNA expression level of HMGBI, PCNA and VEGF in MSC, Real-time PCR was used. Total RNA of each clone was extracted with TRlzol according to the manufacturer's protocol. Reverse-transcription was carried out using M-MLV, and cDNA amplification was carried out using SYBR Green Master Mix kit according to the manufacturer's protocol. HMGB I gene was amplified using specific oligonucleotide primer and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an endogenous control. The PCR primer sequences were as follows:
Data were analyzed using the comparative Ct method (2""''''°). Three separate experiments were performed for each clone.
Western blot assay
MSC were harvested and extracted using lysis buffer (Tris-HCI, SDS, Mercaptoethanol, Glycerol). Cell extracts were boiled for 5 min in loading buffer and then equal amounts of cell extracts were separated on 15% SDS-PAGE gels. Separated protein bands were transferred into polyvinylidene fluoride (PVDF) membranes and the membranes were blocked in 5% skim milk powder. The primary antibodies against HMGB 1, PCNA and VEGF were diluted according to the instructions ofantibodies and incubated overnight at 4°C. Then, horseradish peroxidaselinked secondary antibodies were added at a dilution ratio of I: 1000, and incubated at room temperature for 2 h. The membranes were washed with PBS for three times and the immunoreactive bands were visualized using ECL-PLUSlKit according to the kit's instruction. The relative protein level in different cell lines was normalized to GAPDH concentration. Three separate experiments were performed for each clone.
Animal model and reendothelialization analysis
Adult male rats weighing 220-250g were used in this study. A middle cerebral artery occlusion was established. Rats were initially anesthetized with 10% chloral hydrate. Rectal temperature was controlled at 37°C with a feedback-regulated water heating system. The right common carotid artery, external carotid artery (ECA), and internal carotid artery were exposed. A 3.0 monofilament nylon suture with its tip rounded by heating near a flame was advanced from the ECA into the lumen of the internal carotid artery until it blocked the origin of the middle cerebral artery. Animals were reanesthetized with halothane, and reperfusion was performed by withdrawal the suture until the tip cleared the lumen of the ECA.
MSC (5 X 10 5 cells) were resuspended in 100 ul of pre-warmed PBS and transplanted 3 h after carotid artery injury via tail vein injection with a needle. The same volume of PBS was injected into placebo mice. Three days after carotid artery injury, endothelial regeneration was evaluated by staining denuded areas with 100 f.ll of solution containing 3% Evans Blue dye via tail vein injection. Fluorescence microscopy (Olympus) was performed to detect the homing of transplanted MSC to the site of vascular injury in separate experiments.
Immunohistochemical staining
Immunostaining for HMGB I, PCNA and VEGF using monoclonal antibodies was performed. Unstained sections were deparaffinized and incubated overnight at 4°C with primary antibodies against the proteins, then with biotinylated secondary antibody (1:200) at room temperature for I h, followed by incubationwithABC peroxidase and 3,3' diaminobenzidine (DAB; 30 mg dissolved in 100 ml Trisbuffer containing 0.03% HP2)' Sectionswere counterstained with hematoxylin. Digital images were acquired and semiquantitative analysis was performed.
ELISA assay
ELISA used to detect the levels of serum TNF-a and CRP in MSC-transplanted rats was performed using ELISA kit. Serum was cultured in I ml of complete medium in absence of different stimuli in 6-well plates (Costar). After incubation for specified periods of time at 37°C, culture supernatants were obtained. The concentrations of TNF-a and CRP were then measured according to the manufacturer's instructions.
Statistical analysis
The result of each experiment was shown as mean ± SO where applicable. Statistically significant difference in each assay was determined by SPSS version 11.5. Difference in each group was tested for significance using ANOVA analysis of variance. P <0.05 was considered significant.
RESULTS
Phenotypic characterization ofMSC
MSC were scattered in a number of colony distributions 3 days after planting. At 9 th day, the bottle was covered with long-spindle cells. Passage cells (mostly spindle cells) were uniforml y distributed, and covered the bottom every 4~5 days (Fig. IA) . The 3rd Passage MSC highly expre ssed the surface marker molecule CD29 (98.05%) and lowly expressed the blood cell surface molecule CD45 (3.74%) ( Fig. I B) .
Effects ofgene transduction on HMGBl , PCNA and VEGF expression
After infection with HMGB I adeno virus (MOI=600), MSC had high infection efficiency, more that 85.0% ( Fig. 2A) . To examin e the effects of ad5G FP-HMGBI on expression of HMGBI , PCNA and VEGF in MSC, their expression levels were measured by Real-time PCR and Western blot assays . As shown in Fig. 2 , Band C, an obvious increase of HMGB I, PCNA and VEGF expression was observed in ad5GFP-HMGB Igroup compared with the ad5GFP and MSC groups.
HMGBI gene transf er enhanced in vivo reendothelialization capacity of MSC
The carotid endot helium injury was confirmed by Evans Blue staining (Fig. 4A ). Fluorescent microscope analysis of a subgroup of rats (n=6) revealed that, transplanted MSC attached at the site of vascular injury and tended toward s endothelialization ( Fig. 3A-D) . Moreo ver, we hypothesized that the enhanced function in vitro achieved by HMGB I gene transfer would translat e into improved function in vivo. To test this hypothesis, MSC , Ad5GFP-transduced MSC, and Ad5GFP-HMGBItransduced MSC were systemically injected into the rats subjected to carotid artery injury. Notably, compared with the MSC, treatment with Ad5GFPtransdu ced MSC or Ad5GFP-HMGB I-transduced MSC obviousl y increased reendoth elialization of denuded carotid arteries, and Ad5GFP-HMGB I had the enhanced effect on MSC (Fig. 4B) .
Immunoh istochemistry analysis of HMGBl, PCNA and VEGP expression
To verify the effects of HMGB I-modified MSC on PCNA and VEGF expression in vivo, it was evaluated immunohistochemically. Their prote in expression was significantly increased in vascular injury rats treated with Ad5GFP-HMGBI compared with the Ad5GFP-HMGB I and MSC groups (Fig.  72h B . . 
5, A-D).
ELISA analysis ofserum TNF-a and CRP levels
To investigate the effects of HMGB I-modified MSC on serum TNF-a and CRP levels in vascular injury rats, they were evaluated using ELISA assay. As shown in Table I , serum TNF-a and CRP levels were markedly decreased in Ad5GFP-HMGBl group compared with the Ad5GFP-HMGBI and MSC groups.
DISCUSSION
Cellular therapy for cardiovascular disease heralds an exciting frontier of research. It has been demonstrated that MSC have the capacity to facilitate myocardial repair and neovascularization in models of cardiac injury and may become an attractive adult-derived cell population for cardiovascular repair (17) . VEGF is a critical paracrine mediator in facilitating postischemic myocardial recovery and likely plays a role in mediating the observed age threshold during stem cell therapy. Combined VEGF and MSC treatment is effective in protecting neurons against hypoxic ischemic injury (18, 19) . VEGFmodified MSC implantation can provide advanced benefits in the protection against acute kidney injury by increasing anti-apoptosis effects and improving microcirculation and cell proliferation. MSC expressing VEGF in response to hypoxic stress can be a promising therapeutic strategy for the treatment ofischemic heart disease (20, 21) . MSC may promote the motor function recovery by up-regulating VEGF mRNA expression and increa sing angiogenesis in the spinal cord injury (22) . In the present study, we also found, the expre ssion of VEGF was significantly increased in HMGB l-modified MSC in comparison with the Ad5GFP-transduced MSC and nontransduced MSC using Real-time PCR, Western blot and immunohistochemistry assays . Therefore, modification ofHMGB I may enhance the protective effects of MSC on balloon-induced carotid artery injury through up-regulation ofVEGF expression.
Moreover, MSC enhance tubular proliferation as detected by the increased number of PCNA positive cells and ameliorate tissue damages triggered by renal ischemia and reperfusion injury (23, 24) . Detecting PCNA expression levels may be used for responding the endothelium prolife ration and repair. As a consequence, in the present study, we demonstrated an increased expression of PCNA in HMGB I-modified MSC compared with the Ad5GFP-transduced MSC and nontransduced MSC using Real-time PCR, Western blot and immunohistochemistry assays, suggesting that modification ofHMGB I may enhance the protective effect s of MSC on carotid artery injury through upregulation of PCNA expres sion. Engrafted MSC can differentiate into endothelial cells , dimini sh the neointima formation and contribute to the improvement on endothelial function , exerting an important function as repair mechanism in vascular injury after vein grafting (25) . Progenitor cells confer . plasticity to cardiac valve endothelium and CXCR4+ progenitors derived from MSC differentiate into endothelial cells capable of vascular repair after arterial injury (26, 27) . CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells (28) . However, some studies show that MSC could not exhibit reparative or paracrine protective properties (29) . Confirmation of the exact effects of MSC on vascular injury is needed . In our study, GFP-MSC promoted the endothelial repair after artery injury, and HMGB 1mediated MSC helped to enhance the protecti ve effects on endothelial repair, enriching the evidence of MSC anti-endothelial injury.
Vascular injury causes acute systemic inflammation and mobilize s endothelial progenitor cells and endothelial cell colony-forming units. For one thing, it has been thought that circulating endothelial progenitor cells are not affected by acute (30) . For another, MSC anti-inflammatory effects have been verified in many experiments. Human MSC reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines. They also provide enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation (31, 32) . Intracoronary infusions of MSC improve postischemic left ventricular function and reduce inflammatory signaling via a STAT3dependent mechanism (33) . Meanwhile, in the present study, we found that, serum TNF-a and CRP levels were markedly decreased in the Ad5GFP-HMGBI group compared with the Ad5GFP-HMGBI and MSC groups, suggesting HMGB I-modified MSC might protect the balloon-induced carotid artery injury through inhibition of the inflammatory response.
In conclusion, modification of HMGB 1 can enhance the protective effects of MSC on ballooninduced carotid artery injury through upregulation of VEGF and PCNA expression and inhibition of the inflammatory response. HMGB 1 in MSC may represent a novel therapeutic target for the treatment of endothelial repair.
